why choose us

First received: January 03, 2023

Clinical Trial: Regulatory T Cells for Amyotrophic Lateral Sclerosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Amyotrophic Lateral Sclerosis

Study Type: INTERVENTIONAL


Official Title: Phase 1 Safety Run-in Study and Phase 1b Randomized, Double Blinded, Placebo Controlled Trial

Brief Summary: Phase 1 Safety Run-in Study of 6 patients followed by Phase 1b Randomized, Double Blind, Placebo Control Trial of CK0803, neurotropic, allogeneic, umbilical cord blood derived T regulatory (Treg) cells in additional 60 patients with Amyotrophic Lateral Sclerosis.

Read more